A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis

This study is currently recruiting participants.

Study NCT00217295 Information provided by Multiple Sclerosis Institute

First Received: September 14, 2005 No Changes Posted

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2007
Estimated Primary Completion Date:	No date given